ArticleTransplantation2022
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?
Abstract readLetterComment
In one paragraph
Article in Transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023Pooled it
- Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.Transplant infectious disease : an official journal of the Transplantation Society · 2022Pooled it
- Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: A systematic review of clinical and immunological studies.Frontiers in immunology · 2022Pooled it
- Pre-vaccination immune signatures of children with inborn errors of immunity associate with COVID-19 vaccine response.Human vaccines & immunotherapeutics · 2026Article
- Efficacy and Safety of mRNA-Based COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis.Vaccines · 2026Review
- Article
- Review
- Immunosuppressant and SARS-CoV-2 Vaccine Antibody Response After Lung Transplantation.Transplantation proceedings · 2022Article
- Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022Article
- Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.Vaccine · 2022Review
- Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study.Vaccines · 2022Article
- Article
- Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome.Journal of clinical medicine · 2022Article
- Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease.PloS one · 2022Article
Corrections and comments
- Comment on
Authors and funding
24 authors.
Nicola CotugnoAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Chiara PighiAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Elena MorrocchiAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Alessandra RuggieroAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Donato AmodioAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Chiara MedriAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Luna ColagrossiMicrobiology and Diagnostic Immunology Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Cristina RussoMicrobiology and Diagnostic Immunology Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Silvia Di CesareAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Veronica SantilliAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Emma Concetta MannoAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Paola ZangariAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Carmela GiancottaAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Stefania BernardiAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Luciana NicolosiAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Marta Ciofi Degli AttiAcademic Department of Pediatrics (DPUO), Infectious Disease Unit, IRCCS Bambino Gesu Children's Hospital, Rome, Italy.
Massimiliano RaponiAcademic Department of Pediatrics (DPUO), Infectious Disease Unit, IRCCS Bambino Gesu Children's Hospital, Rome, Italy.
Salvatore ZaffinaDepartment of Pediatrics, IRCCS Bambino Gesu Children's Hospital, Rome, Italy.
Sara AlfieriHealth Directorate, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Richard KirkHealth Directorate, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Carlo Federico PernoMicrobiology and Diagnostic Immunology Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Paolo RossiAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Antonio AmodeoHealth Directorate, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Paolo PalmaAcademic Department of Pediatrics (DPUO), Clinical and Research Unit of Clinical Immunology and Vaccinology, IRCCS Bambino Gesuù Children's Hospital, Rome, Italy.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
BNT162 VaccineCOVID-19COVID-19 VaccinesHumansImmunityLungRNA, MessengerSARS-CoV-2Young AdultBNT162 VaccineCOVID-19 VaccinesRNA, Messenger
Identifiers
PMID
34954734What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.